Mid-term speculation
What if a digital twin helped researchers test treatment strategies?
A computer model of a patient could let researchers ask 'what if?' without the risk. How close are we?
Speculative
Near-term speculation
What if your genome could help select a treatment?
Sometimes it already does. The trick is knowing when a genetic result is truly useful.
Long-shot speculation
What if we could print living tissue that functions inside the body?
Printing shapes is easy. Printing tissue that lives, breathes and connects is not.
Mid-term speculation
What if measuring biological age became clinically useful?
Your birthday says one thing. Your cells might say another. What could a doctor do with that?
Mid-term speculation
What if a therapy were designed around one person’s tumor?
Every tumour carries its own mutations. Could a treatment be built to match them?
Near-term speculation
What if an AI model discovered a promising drug target?
AI can sift biology faster than any lab. Finding a target is the start of the story, not the end.
Mid-term speculation
What if we could detect a cancer before symptoms appeared?
Finding cancer earlier sounds like pure good news. The details are more interesting.
Near-term speculation
What if an MRI scan took a fraction of the time?
Shorter scans could mean less time lying still in a loud tube — and more people scanned per day.
AI + MedicineSpeculative
What If Every Patient Had a Digital Twin? A Thought Experiment About Personalized Medicine
Personalized computer models of the heart and in-silico trials are already used in research and regulation. Scaling them into a living digital twin for every patient raises hard questions of biology, validation and trust.
Thought experiment5 min read